LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Forest Laboratories Inc.
Headquarters:
New York, NY, United States of America
Website:
N/A
Year Founded:
1954
Status:
Acquired
BioCentury
|
Nov 23, 2024
Finance
Latest Jeito bet positions European VC for fourth exit
Mega-round for Alentis spotlights French firm’s investment style
Read More
BioCentury
|
Sep 20, 2021
Finance
Closing Europe’s largest biotech fund at $630M, Jeito readies to build portfolio
French VC gearing up to build portfolio of European companies focused on severe diseases in small patient populations
Read More
BioCentury
|
Jan 9, 2021
Finance
Closing year with flurry of deals, Tordjman’s Jeito fine-tunes its investment strategy
First investments focus on early-stage European cell and gene therapy
Read More
BioCentury
|
Nov 14, 2020
Finance
Jeito adds dry powder to invest in European innovation
French VC attracts €50M from Sanofi, its first investment in a private French fund
Read More
BioCentury
|
Sep 15, 2020
Finance
Cell therapy play Neogene’s $110M series A marks first investment for Tordjman’s Jeito Capital
Start-up Neogene has ties to Kite veterans Belldegrun, Chang
Read More
BioCentury
|
Jan 17, 2020
Financial News
Sofinnova Partners vet Tordjman launches Jeito with €200M first biotech fund
Read More
BioCentury
|
Aug 15, 2019
Company News
Management tracks: New executives at Pfizer spinouts Cerevel and SpringWorks
Read More
BioCentury
|
Jan 5, 2019
Product Development
Bristol-Myers’ next phoenix act?
How Celgene could be BMS’s next chance to reinvigorate growth, deliver on EPS
Read More
BioCentury
|
Jun 16, 2018
Finance
No easy way up
Why execution could be only way for Allergan to turn its stock around
Read More
BioCentury
|
May 5, 2018
Finance
Splitting Ironwood
Why splitting in two could finally give Ironwood and investors their just rewards
Read More
Items per page:
10
1 - 10 of 934